| 9809559 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi +5 more |
2017-11-07 |
| 9708327 |
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
Suzanne BUTTAR, Tracy Ehiwe, Duong Tran, Fang Wang, Christopher Worrall +1 more |
2017-07-18 |
| 9708342 |
Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2, 1-b][1, 3]oxazepin-8-olate |
Irene Chen, Vahid Zia |
2017-07-18 |
| 9682084 |
Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
Irene Chen, Katie Ann Keaton, Scott E. Lazerwith, Vahid Zia |
2017-06-20 |
| 9643956 |
Solid forms of an ASK1 inhibitor |
Mark Andres, Brenda J. Burke Chan, Anna Chiu, Olga Viktorovna Lapina, Stephen P. Lathrop +3 more |
2017-05-09 |